Skip to main content
Clinical Trials/NCT03232047
NCT03232047
Unknown
Not Applicable

A Randomized Control Trial on Computerized Cognitive Training for Individuals With Mild Cognitive Impairment

Peking University1 site in 1 country120 target enrollmentAugust 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
Peking University
Enrollment
120
Locations
1
Primary Endpoint
Composite working memory z score
Last Updated
7 years ago

Overview

Brief Summary

The objective of the study is to evaluate whether memory training combined with executive training could lead to improved cognitive and noncognitive performance in patients with MCI. Furthermore, we will explore the neural correlates underlying the changed performances.

Detailed Description

Introduction: Mild cognitive impairment (MCI) is a clinical condition characterized of a reduction in memory and/or other cognitive processes that are insufficiently severe to be diagnosed as dementia, but are more pronounced than the cognitive decline associated with normal aging. The prevalence of MCI ranges from 3% to 19% in adults older than 65 years; some of these individuals seem to remain stable or return to normal over time, but more than half progress to dementia within 5 years. Thus, MCI represents a critical window of opportunity for intervening and altering the trajectory of both cognitive decline and loss of functional independence in older adults. Cognitive function apart from memory such as executive function is also impaired in patients with MCI. However, no study has yet placed sufficient emphasis on the training of executive function. Objectives: The objective of the study is to evaluate whether memory training combined with executive training could lead to improved cognitive and noncognitive performance in patients with MCI. Furthermore, we will explore the neural correlates underlying the changed performances. Patients and Methods: The proposed study is a single blinded, randomized and controlled trial that will include 120 elderly patients with MCI from the memory clinic. The groups will be randomized to either intervention or waiting-list group. The intervention is computerized combined memory and executive function training performed for 60 minutes x 4 times/week over 26 weeks. A neuropsychological assessment will be administered at baseline and week 4, 12 and 26 after the intervention. The structural and functional MRI, EEG and NIRS will be performed at baseline and week 26 after intervention for a sub-study on the effect of cognitive training on brain structure and function.

Registry
clinicaltrials.gov
Start Date
August 1, 2017
End Date
December 31, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Peking University
Responsible Party
Principal Investigator
Principal Investigator

Huali Wang

Director of Clinical Research Division

Peking University

Eligibility Criteria

Inclusion Criteria

  • An objective cognition impairment (a Montreal Cognitive Assessment (MoCA) score \< 26)
  • Preserved general cognitive function( an mini-mental state examination (MMSE) score of \> 24)
  • Clinical Dementia Rating (CDR) = 0.5
  • Hamilton Depression Scale (HAMD) score of \< 12
  • Intact activities of daily living (ADL score of \<=26)
  • Schooling education \> = 5 years)
  • Not meeting the diagnosis of dementia (according to the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) and the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) Probable Alzheimer's Criteria

Exclusion Criteria

  • Serious visual or hearing impairment;
  • Hachinski Ischemia Scale (HIS) \>= 4;
  • Subjects with Axis I disorders listed in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), any other neurological disorders that could affect cognitive function;
  • currently on titration of medications with cognitive enhancers or antidepressants;
  • having any physical condition that could preclude regular attendance and full intervention-program participation

Outcomes

Primary Outcomes

Composite working memory z score

Time Frame: Change from baseline composite working memory z score at week 26

composite score of digit span and spatial span

Secondary Outcomes

  • Mood(Change from baseline composite mood score at week 26)
  • Brain structural imaging(change from baseline cortical thickness at week 26)
  • Brain Functional Imaging(change from baseline functional connectivity at week 26)
  • cognitive test package (CTP)(Changes from baseline composite CTP score at week 26)
  • Electrical activity of the brain(change from baseline electrical brain activity at week 26)
  • Self evaluated memory ability(Change from baseline self evaluated memory ability at week 26)
  • cerebral blood flow(change from baseline cerebral blood flow at week 26)
  • BDNF level(change from baseline serum BDNF level at week 26)
  • Composite of overall cognition z scores(Changes from baseline composite overall cognition z score at week 26)

Study Sites (1)

Loading locations...

Similar Trials